A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.
about
Opioids and Viral Infections: A Double-Edged SwordRevolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligandsOpiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.G Protein-Coupled Receptor Heteromers.A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay.
P2860
Q26742182-5D5809CE-3770-498B-8012-63CEAB7C341FQ34424009-5CD515E5-E19F-47C4-88B2-82D7D3AF582FQ35007339-599476C4-CBA4-4E91-A56C-F9E7ECDC89ABQ35216669-D82E9371-F279-4D30-94F1-0C70975A4C3BQ35236118-93B80E99-8B06-4CD2-AAD5-C59931E51536Q35763921-7C14F0A0-14CD-48B5-8992-78539B2FD0F1Q37489251-5CB36DE8-5C63-48A4-89F9-C0267527FF0EQ37570243-1FAC7A50-63B5-4A72-9C6A-1D7CA1271205Q37573308-18172E30-3C47-4F92-A03C-068BA0E5B6AAQ40487821-2D65EF27-0708-4024-BCAF-B43CF13E53A7Q45073147-FA32D6B6-4D5F-40F9-9497-E0F9CF6A4FACQ49754648-F0985A86-FAB1-475D-93E1-89E0177A692F
P2860
A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A Bivalent Ligand Targeting th ...... versus Functional Activities.
@en
type
label
A Bivalent Ligand Targeting th ...... versus Functional Activities.
@en
prefLabel
A Bivalent Ligand Targeting th ...... versus Functional Activities.
@en
P2093
P2860
P356
P1433
P1476
A Bivalent Ligand Targeting th ...... versus Functional Activities.
@en
P2093
Christopher K Arnatt
Dana E Selley
Joanna C Jacob
Kurt F Hauser
Nazira El-Hage
Seth M Dever
Yunyun Yuan
P2860
P304
P356
10.1039/C3MD00080J
P577
2013-05-01T00:00:00Z